American Herbal Products Association (AHPA) > News > Alerts > Market Alerts

Text/HTML

Market Alerts

September 2020

August 2020

July 2020

June 2020

April 2020

February 2020

January 2020

  • Sabinsa's parent company Sami Labs breaks ground on $30 million state of the art production facility
  • Unstoppable Moms Across America launches new Gold Standard to shift the marketplace for a healthier planet
  • Draco Achieves Safe Quality Food (SQF) certification of its manufacturing facilities
  • August 2019

    June 2019

    May 2019

    March 2019

    February 2019

    January 2019

    December 2018

    November 2018

    October 2018

    September 2018

    August 2018

    July 2018

    May 2018

    April 2018

    March 2018

    February 2018

    January 2018

    December 2017

    November 2017

    October 2017

    September 2017

    August 2017

    July 2017

    June 2017

    IADSA update on international supplement regulations

    IADSA update on international supplement regulations

    September 2020 IADSA Newsflash

    In this issue of the IADSA Newsflash:  France alerts consumers about food supplements with claims of curing or preventing COVID-19; Israel notifies WTO about revised limits for polyaromatic hydrocarbons (PAHs) in food supplements; Brazil's new resolution mandating a label when food supplements have a new formulation; Ecuador issues rules for cannabis (hemp seed) supplements; and Peru has established a basic regulation governing health claims applicable to supplement products.

    Supplement and Hemp Industry Associations Applaud Bipartisan Legislation to Regulate Hemp-Derived CBD

    Bill directs FDA to use its authority and resources to set a clear regulatory framework for hemp and hemp derived CBD

    the four leading dietary supplement industry associations applaud Representative Kurt Schrader (D-OR) and Representative Morgan Griffith (R-VA), for introducing bipartisan legislation that would protect public health by providing legal clarity in the cannabidiol (CBD) product marketplace. The Hemp and Hemp derived CBD Consumer Protection and Market Stabilization Act of 2020 directs the U.S. Food and Drug Administration (FDA) to use its authority and resources to set a clear regulatory framework for hemp and hemp derived CBD and assure consumer protection.
    AHPA Hemp-CBD Supplement Virtual Congress

    AHPA Hemp-CBD Supplement Virtual Congress

    On-demand -- Recorded Aug. 27

    AHPA's second, annual Hemp-CBD Supplement Congress was presented on August 27, 2020 and provides companies with an understanding of federal and state legal and regulatory obligations and current issues and opportunities in the hemp-CBD market. This event delivers the latest information to you on-demand.

    AHPA Virtual Sports Nutrition Congress

    October 21, 2020 -- 8am-4:30pm PT -- Virtual Event

    AHPA is excited to present the inaugural Sports Nutrition Congress on Oct. 21 as a virtual event. AHPA's Sports Nutrition Congress will showcase industry experts discussing key sports nutrition industry issues to provide the most up-to-date information, resources and practical tools and guidelines to help ensure the long-term success of your business. You will not want to miss this unique interactive event from the comfort of your home or office.

    AHPA Statement on oleandrin and Nerium oleander

    AHPA strongly discourages sales or marketing of dietary supplements that contain any part of the oleander plant

    Over the last few days, the potential use of oleandrin for treatment of COVID-19 has received significant media attention. The American Herbal Products Association (AHPA) strongly discourages sales or marketing of dietary supplements that contain any part of the oleander plant (Nerium oleander) or its constituent, oleandrin. AHPA also urges physical and online retailers to refrain from offering any such products for sale, and AHPA cautions consumers to avoid oral consumption of oleander or oleandrin.
    IADSA update on international supplement regulations

    IADSA update on international supplement regulations

    July 2020 IADSA Newsflash

    This issue of the IADSA Newsflash covers Australia TGA reclassifies certain sports supplements to be regulated as medicines, South Africa down scheduled CBD to a category of complementary medicine, Korea has updated its functional food code to include ginseng as helpful to bone health and the European Commission (EC) acknowledges the potential to consider traditional use of botanicals in the efficacy assessment of health claims when traditional medicine products exist for botanicals used in foods.

    Sustainability Self-Assessment Tools & Standards

    Recorded July 22, 2020 -- Duration: 2 hours

    Webinar presenters will address different approaches to sustainability self-assessment, discuss various sustainability standards, and how to create realistic science based targets, and present examples that will help companies of all sizes plan and execute meaningful self-assessments.

    AHPA requests USDA APHIS amend and delay Phase VI of the import declarations enforcement schedule

    “Other” essential oils should be removed from the list of products covered under Phase VI

    In comments submitted to the U.S. Department of Agriculture (USDA) Animal and Plant Health Inspection Service (APHIS), AHPA requests the agency to amend Phase VI of its import declarations enforcement schedule by removing “other” essential oils from the list of products covered under this phase.

    AHPA requests adequate federal funding for USPS

    AHPA members depend on the Postal Service to transport herbal products

    AHPA President Michael McGuffin sent a letter to Congressional leaders in the U.S. House and Senate to request adequate federal funding be included in a fourth COVID-19 relief package to ensure the financial viability and continued operations of the United States Postal Service (USPS).

    Case Studies - Substantiating Claims for Herbal Immune Support Products

    Webinar recorded June 17, 2020

    Webinar presenters explain ways to ensure your marketing claims for herbal immune support products are substantiated, truthful and not misleading. Industry experts review several methods they’ve used to ensure their dietary supplement product claims are well substantiated, including: randomized, controlled clinical trials on a well-known elderberry product; in vitro testing to support the legitimacy of the product; and the relevance of use and training in substantiating the effectiveness of traditional Chinese herbal formulations.

    RSS
    12345678910 Last

    2020 Annual Fund Sponsors

       

    AHPA appreciates the support of its sponsors, but does not endorse, recommend, or provide a warranty for any sponsor company, its products or services. AHPA has no responsibility for any transaction entered into with any of these companies.